Welcome to our dedicated page for Octave Specialty Group SEC filings (Ticker: OSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Octave Specialty Group, Inc. filings document the formal disclosure record for a specialty insurance company built around insurance distribution and underwriting businesses. Form 8-K reports cover quarterly results, P&C premium production, commission income, and segment commentary for Insurance Distribution and Everspan. Other current reports disclose material definitive agreements, including amendments to credit arrangements involving Octave subsidiaries and ArmadaCare-related borrowers.
Proxy filings cover annual meeting procedures, shareholder voting matters, board governance, and executive compensation. The record also includes capital-structure and governance disclosures for Octave common stock.
Octave Specialty Group director Joan M. LammTennant received a grant of 7,441 restricted stock units (RSUs), each representing a contingent right to one share of common stock.
The RSUs were granted on April 1, 2026 and are scheduled to vest on April 1, 2027. Vested RSUs will convert into common shares on the earlier of the vesting date or when she ceases to serve on the Board, unless she elects to defer settlement. Following this award, she directly holds 16,091 RSUs tied to Octave Specialty Group common stock.
Matus Kristi Ann reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. director Kristi Ann Matus received a grant of 7,441 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the company’s common stock. Following this grant, she holds 16,091 RSUs directly.
The RSUs granted on April 1, 2026 are scheduled to vest on April 1, 2027. Once vested, they will settle into common shares on the earlier of the vesting date or the date she ceases to serve on the Board of Directors, subject to any deferral election.
Octave Specialty Group director Michael D. Price received a grant of restricted stock units as equity compensation. On April 1, 2026, he was awarded 7,441 RSUs, each representing a right to receive one share of common stock. Following this award, his directly held RSUs total 16,091.
The RSUs granted on April 1, 2026 are scheduled to vest on April 1, 2027. Vested RSUs will convert into common shares on the earlier of the vesting date or when he ceases to serve on the Board of Directors, subject to any deferral election.
Octave Specialty Group’s Chief Accounting Officer, Cristina E. Ahn, reported routine equity compensation activity and tax withholding transactions. On March 23, 2026, she received a grant of 8,067 restricted stock units (RSUs) as part of her 2026 Long Term Incentive Plan award, bringing her RSU holdings to 9,718.
Footnotes state each RSU represents a right to receive one share of common stock, vesting in three equal annual installments starting on March 23, 2027, then on March 23, 2028 and March 23, 2029. On March 10, 2026, 835 RSUs were settled into 835 shares of common stock, and 203 shares were withheld at $4.90 per share to cover tax obligations, leaving 632 common shares directly held after withholding.
Smith R Sharon reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc reported that Executive Vice President and Group COO Sharon R. Smith received a grant of 24,375 restricted stock units as part of her 2026 Long Term Incentive Plan award. Each unit represents a right to receive one share of common stock.
The RSUs vest in three equal annual installments on March 23, 2027, March 23, 2028, and March 23, 2029. Following this award, her reported holdings of this derivative security total 120,314 units, reflecting ongoing equity-based compensation tied to long-term company performance.
Trick David reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. executive vice president, CFO and treasurer David Trick received a grant of 26,250 restricted stock units (RSUs) on March 23, 2026 as part of his 2026 Long Term Incentive Plan award. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest in three equal annual installments on March 23 of 2027, 2028 and 2029. After this award, Trick directly holds 138,184 shares or share-equivalent units in the company.
METZ LAWRENCE F. reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. reported that officer Lawrence F. Metz received a grant of 28,246 restricted stock units as part of his 2026 Long Term Incentive Plan award. Each RSU represents a right to receive one share of common stock. The RSUs vest in three equal annual installments on March 23, 2027, March 23, 2028, and March 23, 2029, aligning compensation with long-term company performance.
Octave Specialty Group Inc.'s Chief Executive Officer Claude LeBlanc reported equity award activity on March 3, 2026. He acquired 47,130 Restricted Stock Units (RSUs) upon vesting of portions of his 2023 and 2024 RSU awards, each RSU representing one share of common stock.
On the same date, 22,582 RSUs were converted into an equivalent number of Deferred Share Units (DSUs) under the company’s Executive Stock Deferral Plan, allowing him to defer settlement and income taxation. In addition, 24,548 shares of common stock were acquired through derivative conversion, while 10,694 shares of common stock were withheld by the company at $5.60 per share to cover tax obligations.
Octave Specialty Group executive David Trick reported equity award activity involving restricted and deferred stock units. On March 3, 2026, he acquired 11,505 shares through the exercise and settlement of restricted stock units and 9,790 deferred share units, each representing one share of common stock.
He also acquired 1,715 shares of common stock upon RSU vesting and simultaneously disposed of 1,715 shares at $5.60 per share to satisfy tax withholding obligations. After these transactions, his directly held common stock position increased to 260,631 shares.
Octave Specialty Group executive R. Sharon Smith reported equity award settlements and related tax withholding. Smith acquired 10,261 shares of common stock through vesting of 2023 and 2024 restricted stock unit (RSU) awards, with 8,720 RSUs converted into deferred share units under the company’s executive stock deferral plan. A further 1,541 common shares were issued and the same number immediately withheld at $5.60 per share to cover tax obligations, leaving direct holdings of 149,182 common shares, 95,939 RSUs and 67,486 deferred share units.